Status:

TERMINATED

Thrombolysis Using Tenecteplase (Metalyse®) in Cardiac Arrest - The TROICA Trial

Lead Sponsor:

Boehringer Ingelheim

Conditions:

Heart Arrest

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The general aim of this study is to compare the efficacy and safety of tenecteplase to standard treatment during cardiopulmonary resuscitation in patients suffering from out-of-hospital cardiac arrest...

Detailed Description

The trial is a prospective, international, multi-centre, randomised (1:1), double-blind, parallel group comparison conducted for investigating the efficacy and safety of tenecteplase and placebo in pa...

Eligibility Criteria

Inclusion

  • Patients, indicated for pre-hospital ALS-CPR procedures\* must fulfil the following inclusion criteria:
  • Age at least 18 years (known or estimated; no upper limit)
  • Out-of-hospital cardiac arrest of presumed cardiac origin (including recurrent cardiac arrest(s) after initial ROSC)
  • Witnessed (by eye and/or ear) cardiac arrest
  • BLS-CPR started within 10 min of onset (known or estimated time) and may be performed for up to 10 min, followed by ALS-CPR - or ALS-CPR started within 10 min of onset (known or estimated time)
  • Subjects who meet any of the following criteria will be excluded from randomisation into the study:
  • In-hospital cardiac arrest
  • Cardiac arrest of presumed non-cardiac origin (e.g., drug overdose, carbon monoxide poisoning, drowning, hypothermia, exsanguination, electrocution, asphyxia, hypoxia, trauma, cerebrovascular accident)
  • Obvious significant internal bleeding
  • Known neurological impairment
  • Known coagulation disorder
  • Known pregnancy
  • Known current participation in any other clinical study
  • Known hypersensitivity to study medication
  • Institutionalised subjects (e.g., prisoner)
  • Any other condition that the investigator feels would place the patient at increased risk if the investigational therapy is initiated

Exclusion

    Key Trial Info

    Start Date :

    January 1 2004

    Trial Type :

    INTERVENTIONAL

    End Date :

    June 1 2006

    Estimated Enrollment :

    1050 Patients enrolled

    Trial Details

    Trial ID

    NCT00157261

    Start Date

    January 1 2004

    End Date

    June 1 2006

    Last Update

    October 29 2013

    Active Locations (68)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 17 (68 locations)

    1

    Univ.-Klinik f. Anaesthesie Graz

    Graz, Austria, 8036

    2

    Univ.-Klinik f. Anaesthesie u. Intensivmedizin

    Innsbruck, Austria, 6020

    3

    LKH Salzburg, St. Johanns-Spital

    Salzburg, Austria, 5020

    4

    Univ.-Klinik f. Notfallmedizin

    Vienna, Austria, 1090

    Thrombolysis Using Tenecteplase (Metalyse®) in Cardiac Arrest - The TROICA Trial | DecenTrialz